Metropolis Healthcare Limited (METROPOLIS) - Total Assets
Based on the latest financial reports, Metropolis Healthcare Limited (METROPOLIS) holds total assets worth Rs19.93 Billion INR (≈ $215.49 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Metropolis Healthcare Limited debt service capacity to assess how comfortably operating cash covers total debt obligations.
Metropolis Healthcare Limited - Total Assets Trend (2014–2025)
This chart illustrates how Metropolis Healthcare Limited's total assets have evolved over time, based on quarterly financial data. See Metropolis Healthcare Limited (METROPOLIS) shareholders funds for net asset value and shareholders' equity analysis.
Metropolis Healthcare Limited - Asset Composition Analysis
Current Asset Composition (March 2025)
Metropolis Healthcare Limited's total assets of Rs19.93 Billion consist of 18.5% current assets and 81.5% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs29.73 Million | 2.1% |
| Accounts Receivable | Rs1.48 Billion | 7.9% |
| Inventory | Rs478.41 Million | 2.6% |
| Property, Plant & Equipment | Rs3.61 Billion | 19.3% |
| Intangible Assets | Rs4.97 Billion | 26.6% |
| Goodwill | Rs5.90 Billion | 31.6% |
Asset Composition Trend (2014–2025)
This chart illustrates how Metropolis Healthcare Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Metropolis Healthcare Limited (METROPOLIS) market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Metropolis Healthcare Limited's current assets represent 18.5% of total assets in 2025, a decrease from 58.2% in 2014.
- Cash Position: Cash and equivalents constituted 2.1% of total assets in 2025, down from 6.0% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 57.0% of total assets, an increase from 9.0% in 2014.
- Asset Diversification: The largest asset category is goodwill at 31.6% of total assets.
Metropolis Healthcare Limited Competitors by Total Assets
Key competitors of Metropolis Healthcare Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ICON Public Limited Company
F:IJF
|
Germany | €16.51 Billion |
|
Fleury S.A.
SA:FLRY3
|
Brazil | R$13.33 Billion |
|
Guangzhou Kingmed Diagnostics Group Co Ltd
SHG:603882
|
China | CN¥9.20 Billion |
|
Diagnósticos da América S.A
SA:DASA3
|
Brazil | R$21.10 Billion |
|
Cowealth Medical China Co.Ltd.
SHG:603122
|
China | CN¥1.41 Billion |
|
Monash Ivf Group Ltd
AU:MVF
|
Australia | AU$510.21 Million |
|
Cytogen Inc
KQ:217330
|
Korea | ₩62.24 Billion |
|
Sonic Healthcare Ltd
AU:SHL
|
Australia | AU$17.03 Billion |
Metropolis Healthcare Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.16 | 1.64 | 2.65 |
| Quick Ratio | 1.02 | 1.49 | 2.49 |
| Cash Ratio | 0.20 | 0.23 | 0.00 |
| Working Capital | Rs486.06 Million | Rs1.53 Billion | Rs3.14 Billion |
Metropolis Healthcare Limited - Advanced Valuation Insights
This section examines the relationship between Metropolis Healthcare Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 7.23 |
| Latest Market Cap to Assets Ratio | 0.02 |
| Asset Growth Rate (YoY) | 20.1% |
| Total Assets | Rs18.67 Billion |
| Market Capitalization | $334.34 Million USD |
Valuation Analysis
Below Book Valuation: The market values Metropolis Healthcare Limited's assets below their book value (0.02x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Metropolis Healthcare Limited's assets grew by 20.1% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Metropolis Healthcare Limited (2014–2025)
The table below shows the annual total assets of Metropolis Healthcare Limited from 2014 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | Rs18.67 Billion ≈ $201.95 Million |
+20.08% |
| 2024-03-31 | Rs15.55 Billion ≈ $168.17 Million |
+3.56% |
| 2023-03-31 | Rs15.02 Billion ≈ $162.39 Million |
-1.87% |
| 2022-03-31 | Rs15.30 Billion ≈ $165.50 Million |
+52.36% |
| 2021-03-31 | Rs10.04 Billion ≈ $108.62 Million |
+33.52% |
| 2020-03-31 | Rs7.52 Billion ≈ $81.35 Million |
+36.12% |
| 2019-03-31 | Rs5.53 Billion ≈ $59.77 Million |
+4.20% |
| 2018-03-31 | Rs5.30 Billion ≈ $57.35 Million |
+2.95% |
| 2017-03-31 | Rs5.15 Billion ≈ $55.71 Million |
+30.12% |
| 2016-03-31 | Rs3.96 Billion ≈ $42.82 Million |
-14.58% |
| 2015-03-31 | Rs4.64 Billion ≈ $50.13 Million |
+18.07% |
| 2014-03-31 | Rs3.93 Billion ≈ $42.45 Million |
-- |
About Metropolis Healthcare Limited
Metropolis Healthcare Limited, together with its subsidiaries, provides pathology and related healthcare services in India, Africa, South Asia, the Middle East, and internationally. The company offers routine and semi-specialised pathology tests; advanced diagnostics, including genetic, molecular, and cytogenetic testing; preventive healthcare packages and corporate wellness screening; and clinic… Read more